|
Volumn 29, Issue 1-2, 1997, Pages 605-606
|
Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation
a a a a a b a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
METHOTREXATE;
METHYLPREDNISOLONE;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DOSE RESPONSE;
GRAFT REJECTION;
HEART LUNG TRANSPLANTATION;
HEART TRANSPLANTATION;
HUMAN;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TRANSPLANTATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SURVIVAL RATE;
ANTILYMPHOCYTE SERUM;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HEART-LUNG TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LUNG TRANSPLANTATION;
METHOTREXATE;
METHYLPREDNISOLONE;
MUROMONAB-CD3;
TACROLIMUS;
|
EID: 0030944282
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00321-1 Document Type: Conference Paper |
Times cited : (5)
|
References (9)
|